has subject area Anaplastic Lymphoma Kinase Carcinoma, Non-Small-Cell Lung Cost-Benefit Analysis ErbB Receptors Humans Lung Neoplasms Mutation Protein Kinase Inhibitors Protein-Tyrosine Kinases
Keywords Non-small cell lung cancer cost-effectiveness analysis economic evaluation systematic review tyrosine kinase inhibitor